A Safety and Tolerability Study of RJX Drug Product in Healthy Participants

NCT03680105 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

76

Enrollment

INDUSTRY

Sponsor class

Conditions

Critical Limb Ischemia

Interventions

DRUG: RJX
DRUG: Placebo

Sponsor

Reven Pharmaceuticals, Inc.

Collaborators

[object Object]
[object Object]